Haixin Co., Ltd. announced that Jiangxi Gannan Haixin Pharmaceutical Co., Ltd., the holding subsidiary of the company, recently obtained the approval and issuance of the chemical “Vitamin B12 Injection” and “Drug Supplement Application Approval Notice” from the State Drug Administration. The drug has passed the consistent evaluation of the quality and efficacy of generic drugs, and the specification is 1 ml: 1 mg. Vitamin B12 injections are mainly used for megaloblastic anemia, and can also be used as an adjuvant treatment for neuritis. This matter will help enhance the competitiveness of the product market and will not have a significant impact on the company's current business performance.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.